Rossi, Monica
 Distribuzione geografica
Continente #
NA - Nord America 153
EU - Europa 140
AS - Asia 36
AF - Africa 4
Totale 333
Nazione #
US - Stati Uniti d'America 148
IT - Italia 49
SE - Svezia 35
IE - Irlanda 15
SG - Singapore 15
CN - Cina 14
FR - Francia 14
DE - Germania 10
CA - Canada 5
CZ - Repubblica Ceca 5
CI - Costa d'Avorio 3
IN - India 3
RU - Federazione Russa 3
BE - Belgio 2
FI - Finlandia 2
TR - Turchia 2
CH - Svizzera 1
DZ - Algeria 1
ID - Indonesia 1
IR - Iran 1
LI - Liechtenstein 1
NL - Olanda 1
RO - Romania 1
UA - Ucraina 1
Totale 333
Città #
Chandler 34
Ashburn 18
Dublin 15
Ann Arbor 12
Milan 9
New York 8
Rome 8
Dearborn 5
Princeton 5
Singapore 5
Jacksonville 4
San Mateo 4
Toronto 4
Wilmington 4
Abidjan 3
Boston 3
Brno 3
Florence 3
Marseille 3
Moscow 3
Tianjin 3
Woodbridge 3
Augusta 2
Bagnoli Irpino 2
Boardman 2
Brussels 2
Cattolica 2
Changsha 2
Essen 2
Fairfield 2
Hefei 2
Houston 2
Izmir 2
Leawood 2
Los Angeles 2
Seattle 2
Amsterdam 1
Bern 1
Brdo 1
Bremen 1
Chicago 1
Falkenstein 1
Hebei 1
Helsinki 1
Lappeenranta 1
Lima 1
Munich 1
Nanjing 1
Norwalk 1
Ottawa 1
Palermo 1
Phoenix 1
Pune 1
Redwood City 1
Salò 1
Shenyang 1
Siziano 1
Sleman 1
Tuzla 1
Vaduz 1
Vigevano 1
Washington 1
Totale 213
Nome #
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 72
Changes in protein serum levels during stem cell transplantation 66
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 65
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 39
An Immersive Motor Protocol for Frailty Rehabilitation 31
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 26
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 25
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer 16
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 9
Totale 349
Categoria #
all - tutte 2.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 6 0 1 4 5 5 2 1 7 1 6 0
2020/202117 1 0 0 1 0 2 1 0 7 2 1 2
2021/202262 8 0 2 5 3 0 2 6 2 4 17 13
2022/2023118 21 13 8 11 7 13 8 9 10 9 5 4
2023/202498 6 15 4 5 1 19 11 1 0 7 19 10
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 349